Literature DB >> 23299623

Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.

Matej Skorvanek1, Iveta Nagyova, Jaroslav Rosenberger, Martina Krokavcova, Radka Ghorbani Saeedian, Johan W Groothoff, Zuzana Gdovinova, Jitse P van Dijk.   

Abstract

Clinical and psychosocial factors associated separately with primary and secondary fatigue in Parkinson's disease (PD) patients have not been thoroughly studied before. The aim of our study was to assess factors associated with different fatigue domains in groups with primary and secondary fatigue in PD separately. We divided 165 non-demented PD patients according to the absence/presence of depression, anxiety and excessive somnolence into groups with primary fatigue (N = 63) and with secondary fatigue (N = 102). Fatigue domains examined using the multidimensional fatigue inventory were associated through multiple linear regression analyses for each group separately with sociodemographic data, disease duration, functional status as assessed by the Unified Parkinson's Disease Rating Scale, treatment, depression, anxiety, excessive somnolence and sleep quality. Out of the assessed non-motor symptoms, fatigue was the most frequent (77.6%). The prevalence of fatigue in the secondary fatigue group was significantly higher than in the primary fatigue group. Both fatigue groups differed significantly in factors associated with different fatigue domains. Functional status or other disease-related factors were not associated with primary fatigue. In the secondary fatigue group, we found associations between some fatigue domains and functional status, older age, male gender and higher anxiety scores. To our knowledge, this is the first study to separately describe clinical determinants and psychosocial factors associated with different fatigue domains in primary and secondary fatigue in PD, underlining the importance of distinguishing primary and secondary fatigue in future PD studies and clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 23299623     DOI: 10.1007/s00415-012-6828-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  42 in total

1.  Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.

Authors:  Dan A Mendonça; Krishe Menezes; Mandar S Jog
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

2.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  The Parkinson fatigue scale.

Authors:  R G Brown; A Dittner; L Findley; S C Wessely
Journal:  Parkinsonism Relat Disord       Date:  2005-01       Impact factor: 4.891

4.  Fatigue in patients with Parkinson's disease.

Authors:  K Karlsen; J P Larsen; E Tandberg; K Jørgensen
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease.

Authors:  Juan Carlos Gómez-Esteban; Beatriz Tijero; Johanne Somme; Roberto Ciordia; Koldo Berganzo; Idoia Rouco; Jose Luis Bustos; Maria Antonia Valle; Elena Lezcano; Juan J Zarranz
Journal:  J Neurol       Date:  2010-10-19       Impact factor: 4.849

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.

Authors:  Jau-Shin Lou; Greg Kearns; Theodore Benice; Barry Oken; Gary Sexton; John Nutt
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

10.  Impact of fatigue on quality of life in patients with Parkinson's disease.

Authors:  E Havlikova; J Rosenberger; I Nagyova; B Middel; T Dubayova; Z Gdovinova; J P van Dijk; J W Groothoff
Journal:  Eur J Neurol       Date:  2008-03-05       Impact factor: 6.089

View more
  9 in total

Review 1.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

2.  The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners.

Authors:  Allison Hicks; Kala Phillips; Chelsea Siwik; Paul Salmon; Irene Litvan; Megan E Jablonski; J Vincent Filoteo; Karen Kayser; Sandra E Sephton
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

3.  Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease.

Authors:  Sneha Mantri; Lana M Chahine; Karina Nabieva; Robert Feldman; Andrew Althouse; Benjamin Torsney; Steven M Albert; Catherine Kopil; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2021-10-28

Review 4.  The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management.

Authors:  Vladimir S Kostić; Aleksandra Tomić; Milica Ječmenica-Lukić
Journal:  Mov Disord Clin Pract       Date:  2016-03-11

5.  Risk Factors of Fatigue in Idiopathic Parkinson's Disease in a Polish Population.

Authors:  Monika Gołąb-Janowska; Dariusz Kotlęga; Krzysztof Safranow; Agnieszka Meller; Anna Budzianowska; Krystyna Honczarenko
Journal:  Parkinsons Dis       Date:  2016-01-26

6.  Acupuncture in the treatment of fatigue in Parkinson's disease: A pilot, randomized, controlled, study.

Authors:  Keng H Kong; Hwee L Ng; Wei Li; Dora W Ng; Siang I Tan; Kay Y Tay; Wing L Au; Louis C S Tan
Journal:  Brain Behav       Date:  2017-12-29       Impact factor: 2.708

7.  Triggers and alleviating factors for fatigue in Parkinson's disease.

Authors:  Iris Lin; Briana Edison; Sneha Mantri; Steven Albert; Margaret Daeschler; Catherine Kopil; Connie Marras; Lana M Chahine
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

8.  Acupuncture in the treatment of fatigue in Parkinson's disease: A protocol for systematic review and meta-analysis.

Authors:  Yingpeng Zhi; Chen Gao
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

9.  Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson's disease prognosis.

Authors:  Yoshiki Niimi; Sayuri Shima; Yasuaki Mizutani; Akihiro Ueda; Shinji Ito; Tatsuro Mutoh
Journal:  Fujita Med J       Date:  2019-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.